The FDA’s Adverse Event Monitoring System (AEMS) illustrates the truth of Stoll and Wilson’s observations. While the agency is celebrating its consolidated, real-time dashboard as a modernization milestone, what the public needs is not just more data, but more action.
Modern Interface, Same Old Problem? Continue Reading
If policymakers focus on separating normative functions from emergency authority, designing time-bound compacts instead of permanent command structures, and tying funding to measurable outcomes, global health cooperation can be rebuilt without recreating the structural distortions that weakened it.
How to Build a Post-WHO Global Health Architecture Continue Reading
The focus should be on cleaning up the food as the path to great American health. The messaging around food polls better, they say, whereas the pressure on vaccine makers and culling of the childhood schedule is a political loser. So they say.
What the Polls Say about the Pharmaceutical Industry and Vaccines Continue Reading
There was a time when the aspirations of Alma Ata drove public health. If the nations of the G20 seek a more stable world, returning its public health approach to evidence and reality could be a step forward.
Closing the Deal: The Misinforming of the G20 on Pandemics Continue Reading
The problem with the America First Global Health Strategy is not that the US is engaged abroad. It is that Washington has wrapped a sprawling, path-dependent set of programs in a nationalist label without doing the hard work that strategy requires.
The Problem with America First Global Health Continue Reading
We owe understanding, catharsis, and lessons learned to the thousands of people whom we allowed to die during Covid and to their loved ones. We owe it to our children whose education, social life, and mental health we significantly disrupted.
The Third Period: My Covid Speech in the Czech Parliament Continue Reading
It’s patients — not governments — who should steer their own medical decisions, once they’ve been fully informed. The story of the PSA test reminds us that well-intentioned medicine can cause real harm when certainty is oversold and humility is lost.
The Prostate Cancer Test Dilemma Continue Reading
There could hardly be a worse time – and I’m not saying there ever was a good time – to entrust politicians with an ambitious digital ID programme plagued with risks of government surveillance, technocratic over-reach, system failures, and data breaches.
Kennedy is correct that it is harder to quit antidepressants than heroin. The abstinence symptoms are short-lived for heroin but not for antidepressants, and psychiatrists who have worked with both types of patients consistently say that heroin is the easier one.
The Information War Over Antidepressants Continue Reading
The shift may prove to be one of the most consequential public health developments of the decade, and it suggests that something significant is moving behind the scenes in the federal agencies that once seemed immovable.
CDC Quietly Rewrites Its Vaccine–Autism Guidance Continue Reading
A global climate, health, or development system that depends on the continuous escalation of crisis narratives is structurally incapable of declaring success. Trump’s decision confronts that reality directly. That, more than the budget line, is what has changed.
Trump’s Withdrawal from 66 Organizations Continue Reading
The central question in the AI debate is not just whether machines can be aligned with human values, but whether modern institutions can be trusted to manage uncertainty without amplifying it.
How a Techno-Optimist Became a Grave Skeptic Continue Reading
